The potential of magnetic resonance visualization of the orbits for diagnostics of endocrine ophthalmopathy
https://doi.org/10.14341/probl20135953-8
Abstract
The present study included a total of 22 patients (44 eyes/orbits) presenting with endocrine ophthalmopathy (EOP) and Graves' disease. All of them underwent routine ophthalmological examination. The activity and severity of EOP were verified in accordance with the EUGOGO recommendations. The MRI protocol included obtaining T1-, T2-weighted, and STIR sequence images of the orbits. quantitative measurement of signal intensity (SI) from extraocular muscles (EOM), and the signal intensity ratio of EOM to ipsilateral temporal muscle (SIR value). The study has revealed the relationship of the minimal, maximum, and average EOM SI with EOP activity and severity. Moreover, it demonstrated direct correlation between SIR and clinical activity of EOP. It is concluded that MRI of the orbits with STIR sequence in the patients suffering EOP provides the additional criteria for the verification of the activity and severity of the disease as well as for prognostication of the response to the immunosuppressive treatment.
References
1. Wiersinga W.M., Perros P., Kahaly G.J., Mourits M.P., Baldeschi L., Boboridis K., Boschi A., Dickinson A.J., Kendall-Taylor P., Krassas G.E., Lane C.M., Lazarus J.H., Marcocci C., Marino M., Nardi M., Neoh C., Orgiazzi J., Pinchera A., Pitz S., Prummel M.F., Sartini M.S., Stahl M., von Arx G. Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 2006; 155: 3: 387-399.
2. Mourits M.P., Koornneef L., Wiersinga W.M., Prummel M.F., Berghout A., van der Gaag R. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol 1989; 73: 8: 639-644.
3. Werner S.C., Coleman D.J., Franzen L.A. Ultrasonographic evidence of a consistent orbital involvement in Graves's disease. N Engl J Med 1974; 290: 26: 1447-1450.
4. Hiromatsu Y., Kojima K., Ishisaka N., Tanaka K., Sato M., Nonaka K., Nishimura H., Nishida H. Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy. Thyroid 1992; 2: 299-305.
5. Hosten N., Sander B., Cordes M., Schubert C.J., Schörner W., Felix R. Graves' ophthalmopathy: MR imaging of the orbits. Radiology 1989; 172: 759-762.
6. Pauleit D., Schueller H., Textor J., Leutner C., Keller E., Sommer T., Träber F., Block W., Boldt I., Schild H. MR relaxation time measurements with and without selective fat suppression (SТIR) in endocrine orbitopathy. Rofo 1997; 167: 6: 557-564.
7. Hoh H.B., Laitt R.D., Wakeley C., Kabala J., Goddard P., Potts M.J., Harrad R.A. The STIR sequence MRI in the assessment of extraocular muscles in thyroid eye disease. Eye 1994; 8: 5: 506-510.
8. Mayer E., Herdman G., Burnett C, Kabala J., Goddard P., Potts M.J. Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid eye disease. Eye 2001; 15: 313-318.
9. Kirsch E.C., Kaim A.H., De Oliveira M.G., von Arx G. Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves' orbitopathy - a pilot study at 1.5 T. Neuroradiology 2010; 52: 91: 97.
10. Rodríguez-González N., Pérez-Rico C., López-Para Giménez R., Arévalo-Serrano J., Del Amo García B., Calzada Domingo L., Flores Ruiz L., Blanco R. Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves' orbitopathy. Arch Soc Esp Oftalmol 2011; 86: 11: 351-357.
Review
For citations:
Vorontsov A.V., Chepurina A.A., Sviridenko N.I., Atarshchikov D.S., Vladimirova V.P. The potential of magnetic resonance visualization of the orbits for diagnostics of endocrine ophthalmopathy. Problems of Endocrinology. 2013;59(5):3-8. (In Russ.) https://doi.org/10.14341/probl20135953-8
Views:
1024
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
